NPAT up 57.6% to $37.2m on a $42.9m portfolio total return

The result was associated with investment total return of $42.9m, well above Annolyse's three-period historical mean of $8.5m and at the upper edge of the supplied range. Cash investment income (dividends and interest) rose 56.7% to $1.2m, also at the upper edge of its historical range (mean $0.8m).

Net assets attributable grew 15.6% to $222.9m, and NTA per share rose 10.8% to $1.03. ROE moved to 16.7% from 12.2%, at the upper edge of the supplied historical range (3-period mean -1.8%). The cash balance fell to $7.2m from $16.2m, and reported operating cash flow swung from +$22.6m to -$2.0m — a portfolio-activity movement rather than a cash-conversion signal for this investment company structure.

Investment total return of $42.9m is exceptionally strong against historical baseline ($8.5m mean), but the benchmark total return was 15.2% — lower edge of Annolyse's historical range, against a 3-period mean of 29.5%. This means the dollar gain came in a year where the market itself was below average; without a disclosed portfolio total return percentage, the relative outperformance read cannot be confirmed from the data supplied.

Distributions remain funded predominantly by capital gains, not cash income. Distribution coverage from investment income improved to 11.8% from 8.6%, but cash dividend and interest income still cover only about an eighth of distributions paid. The remainder relies on realised capital gains, which are market-dependent and lumpy. The payout ratio relative to NPAT was 22.3% (vs 15.6% prior), but NPAT itself is dominated by fair-value movements.

Per-share compounding lags gross portfolio return. Investment total return grew 55.4% year-on-year, yet NTA per share rose only 10.8%. That gap reflects fees, distributions and share-count movements, and is the rate that matters to shareholders rather than the headline portfolio number.

The half-year shape shows HY24 NPAT of $10.2m and full-year NPAT of $37.2m, implying roughly $27.0m of profit was generated in the second half — a 73% second-half weighting that points to favourable late-FY24 market conditions rather than even portfolio earning power. The HY24 revenue figure ($12.4m) is not comparable to FY24 investment income ($1.2m) because the interim line includes fair-value movements that the annual presentation separates out.

Whether the FY24 result is repeatable depends on whether the late-period portfolio gains held or reversed into FY25 — a directional question the release commentary on equity-market volatility flags but does not answer.

Here, $42.9m of investment total return sits alongside only $1.2m of cash investment income, so the FY24 result is overwhelmingly market-direction-dependent, not a stable income stream. That is normal for the structure but should not be read as a recurring earnings base.

The effective tax rate of 3.1% (vs 3.3% prior) is within the supplied historical pattern and is not distorting the comparison. The reported operating cash outflow of $2.0m versus prior inflow of $22.6m reflects net buy/sell activity within the portfolio rather than operating quality, so it should not be interpreted with operating-company cash-conversion language. The more important quality lens is that distributions of 3.93 cps for the year continue to rely on realised gains, and that funding stream is only as durable as portfolio liquidity and prevailing market levels. This is consistent with the context disclosed in the Marlin Global 2024 Annual Report, though no detailed reconciliation of individual position movements has been supplied.

This briefing cannot assess portfolio-versus-benchmark relative performance because the portfolio total return percentage is not disclosed in the supplied data.